Lyme neuroborreliosis in children: Report of nine cases and a review of the literature.
Adolescent
Amoxicillin
/ therapeutic use
Anti-Bacterial Agents
/ therapeutic use
Antibodies, Bacterial
/ blood
Borrelia
/ genetics
Cefotaxime
/ therapeutic use
Ceftriaxone
/ therapeutic use
Child
Child, Preschool
DNA, Bacterial
Facial Paralysis
/ microbiology
Female
France
Humans
Lyme Neuroborreliosis
/ diagnosis
Male
Polymerase Chain Reaction
Borrelia
Children
Lyme disease
Meningitis
Neuroborreliosis
Journal
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
ISSN: 1769-664X
Titre abrégé: Arch Pediatr
Pays: France
ID NLM: 9421356
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
03
04
2018
revised:
07
01
2019
accepted:
09
02
2019
pubmed:
20
3
2019
medline:
21
8
2019
entrez:
20
3
2019
Statut:
ppublish
Résumé
Lyme neuroborreliosis is a bacterial infection caused by the dissemination and proliferation of a Borrelia species in the central nervous system. Neuroborreliosis occurs after transmission of the pathogen from an infected tick to a human host during a tick bite. We report nine cases of pediatric neuroborreliosis collected by the National Observatory of Pediatric Bacterial Meningitis in France between 2001 and 2012. The nine children, aged 4-13 years, were identified in northern and eastern France and had the following clinical features: meningeal irritation alone or with facial palsy, or isolated facial palsy. All cases showed anti-Borrelia antibodies in cerebrospinal fluid or serum, or with a positive Borrelia PCR in the CSF. The outcome was favorable in all cases after a 2- to 3-week course of third-generation cephalosporin. On the basis of these nine pediatric cases, this study provides an update on the epidemiology, pathophysiology, diagnostic strategy, and treatment of neuroborreliosis, with insight into the specific features of pediatric neuroborreliosis and the difficulties encountered in the diagnosis of this infection.
Identifiants
pubmed: 30885602
pii: S0929-693X(19)30034-X
doi: 10.1016/j.arcped.2019.02.010
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antibodies, Bacterial
0
DNA, Bacterial
0
Ceftriaxone
75J73V1629
Amoxicillin
804826J2HU
Cefotaxime
N2GI8B1GK7
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Pagination
133-137Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.